CME Group Inc. CME
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.62B | 1.59B | 1.77B | 1.54B | 1.43B |
| Total Other Revenue | 112.10M | 111.70M | 109.50M | 108.40M | 104.00M |
| Total Revenue | 1.73B | 1.70B | 1.88B | 1.64B | 1.53B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.73B | 1.70B | 1.88B | 1.64B | 1.53B |
| SG&A Expenses | 466.80M | 468.70M | 446.60M | 473.10M | 440.00M |
| Depreciation & Amortization | 83.40M | 84.20M | 83.30M | 82.40M | 82.60M |
| Other Operating Expenses | 41.70M | 42.30M | 36.60M | 39.60M | 39.20M |
| Total Operating Expenses | 591.90M | 595.20M | 566.50M | 595.10M | 561.80M |
| Operating Income | 1.14B | 1.11B | 1.31B | 1.05B | 972.60M |
| Income Before Tax | 1.35B | 1.33B | 1.51B | 1.58B | 1.18B |
| Income Tax Expenses | 317.90M | 285.90M | 356.60M | 395.50M | 269.00M |
| Earnings from Continuing Operations | 1.04B | 1.04B | 1.15B | 1.18B | 908.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.04B | 1.04B | 1.15B | 1.18B | 908.00M |
| EBIT | 1.14B | 1.11B | 1.31B | 1.05B | 972.60M |
| EBITDA | 1.22B | 1.19B | 1.39B | 1.13B | 1.06B |
| EPS Basic | 2.90 | 2.88 | 3.22 | 3.25 | 2.49 |
| Normalized Basic EPS | 2.37 | 2.30 | 2.63 | 2.71 | 2.05 |
| EPS Diluted | 2.89 | 2.88 | 3.18 | 3.24 | 2.49 |
| Normalized Diluted EPS | 2.36 | 2.30 | 2.60 | 2.71 | 2.04 |
| Average Basic Shares Outstanding | 358.02M | 360.68M | 359.33M | 359.63M | 359.69M |
| Average Diluted Shares Outstanding | 358.64M | 361.28M | 363.18M | 360.23M | 360.42M |
| Dividend Per Share | 1.30 | 1.30 | 1.30 | 1.25 | 1.25 |
| Payout Ratio | 44.83% | -- | 233.70% | 38.46% | 50.14% |